Menu
GeneBe

MTTP

microsomal triglyceride transfer protein

Basic information

Region (hg38): 4:99564080-99623997

Previous symbols: [ "MTP" ]

Links

ENSG00000138823NCBI:4547OMIM:157147HGNC:7467Uniprot:P55157AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • abetalipoproteinemia (Strong), mode of inheritance: AR
  • abetalipoproteinemia (Strong), mode of inheritance: AR
  • abetalipoproteinemia (Supportive), mode of inheritance: AR
  • abetalipoproteinemia (Definitive), mode of inheritance: AR
  • abetalipoproteinemia (Definitive), mode of inheritance: AR

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
AbetalipoproteinemiaARGastrointestinalDietary measures (eg, with a low fat diet and supplementation of essential fatty acids and fat-soluble vitamins) can be beneficial, and early initiation can prevent/decrease severe sequelaeGastrointestinal; Hematologic; Neurologic; Ophthalmologic15411425; 14925152; 13745738; 14237436; 4135110; 848999; 716878; 7425890; 6959555; 2339706; 1439810; 8361539; 9686820; 17275380; 18239027; 18611256; 20402070; 21333248; 21394827; 21502686; 23090820; 23556456; 24288038

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the MTTP gene.

  • not provided (810 variants)
  • Abetalipoproteinaemia (233 variants)
  • not specified (27 variants)
  • Inborn genetic diseases (24 variants)
  • MTTP-related condition (5 variants)
  • Metabolic syndrome X;Abetalipoproteinaemia (4 variants)
  • Abetalipoproteinaemia;Metabolic syndrome X (4 variants)
  • RECLASSIFIED - MTTP POLYMORPHISM (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the MTTP gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
2
clinvar
264
clinvar
6
clinvar
272
missense
1
clinvar
1
clinvar
250
clinvar
20
clinvar
2
clinvar
274
nonsense
21
clinvar
29
clinvar
1
clinvar
51
start loss
0
frameshift
35
clinvar
29
clinvar
64
inframe indel
2
clinvar
2
splice donor/acceptor (+/-2bp)
6
clinvar
15
clinvar
21
splice region
1
14
46
2
63
non coding
29
clinvar
80
clinvar
47
clinvar
156
Total 63 74 284 364 55

Highest pathogenic variant AF is 0.0000394

Variants in MTTP

This is a list of pathogenic ClinVar variants found in the MTTP region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
4-99564087-G-C Abetalipoproteinaemia • not specified Benign (Jun 14, 2016)347008
4-99564098-G-A Abetalipoproteinaemia Benign (Jun 14, 2016)347009
4-99564125-G-A Abetalipoproteinaemia • not specified • MTTP-related disorder Conflicting classifications of pathogenicity (Mar 01, 2023)347010
4-99564134-G-A Abetalipoproteinaemia Uncertain significance (Jan 13, 2018)347011
4-99564183-TC-T Uncertain significance (Jun 02, 2021)1678403
4-99564186-C-G Abetalipoproteinaemia Uncertain significance (Jan 12, 2018)347012
4-99564190-C-A Abetalipoproteinaemia Uncertain significance (Jan 13, 2018)347013
4-99564240-G-A MTTP-related disorder Likely benign (Sep 13, 2019)3040642
4-99574331-G-T Benign (Jan 22, 2024)1168852
4-99574660-T-C Benign (Jan 22, 2024)1168853
4-99574826-T-C Abetalipoproteinaemia Uncertain significance (Jan 13, 2018)347014
4-99574828-C-T Abetalipoproteinaemia Uncertain significance (Jan 13, 2018)347015
4-99574856-C-T Abetalipoproteinaemia Uncertain significance (Jan 13, 2018)347016
4-99574882-T-C Abetalipoproteinaemia Uncertain significance (Jan 13, 2018)347017
4-99574882-TGGATGCAGTTGAGGATTGCTGGTCAATATGATTCTTCTTGCTGTGC-T Uncertain significance (Dec 10, 2021)1355447
4-99574890-G-A Abetalipoproteinaemia Uncertain significance (Jan 12, 2018)901151
4-99574904-G-A Abetalipoproteinaemia Likely benign (Aug 01, 2023)347018
4-99574916-CT-C Pathogenic (Jun 25, 2023)2728721
4-99574921-T-TG Likely pathogenic (Aug 01, 2022)1711595
4-99574925-G-T Inborn genetic diseases Uncertain significance (Jan 26, 2022)2273330
4-99574927-G-T Likely benign (Feb 01, 2024)2826623
4-99574929-T-G Uncertain significance (Jul 22, 2022)2194976
4-99574931-T-TCTGAA Abetalipoproteinaemia Likely pathogenic (Feb 28, 2022)1724822
4-99574933-T-C Likely benign (Sep 24, 2022)2030331
4-99574939-C-T Likely benign (May 01, 2023)1557688

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
MTTPprotein_codingprotein_codingENST00000457717 1860239
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.00001041.001256800681257480.000270
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense1.034024640.8660.00002515851
Missense in Polyphen69104.360.661171353
Synonymous0.5381641730.9480.000009991733
Loss of Function3.661641.40.3860.00000204546

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0003050.000304
Ashkenazi Jewish0.002680.00268
East Asian0.0002720.000272
Finnish0.00004620.0000462
European (Non-Finnish)0.0002200.000220
Middle Eastern0.0002720.000272
South Asian0.00009800.0000980
Other0.0001630.000163

dbNSFP

Source: dbNSFP

Function
FUNCTION: Catalyzes the transport of triglyceride, cholesteryl ester, and phospholipid between phospholipid surfaces (PubMed:23475612, PubMed:8939939, PubMed:26224785, PubMed:25108285, PubMed:22236406). Required for the secretion of plasma lipoproteins that contain apolipoprotein B (PubMed:23475612, PubMed:8939939, PubMed:26224785). {ECO:0000269|PubMed:22236406, ECO:0000269|PubMed:23475612, ECO:0000269|PubMed:25108285, ECO:0000269|PubMed:26224785, ECO:0000269|PubMed:8939939}.;
Disease
DISEASE: Abetalipoproteinemia (ABL) [MIM:200100]: An autosomal recessive disorder of lipoprotein metabolism. Affected individuals produce virtually no circulating apolipoprotein B-containing lipoproteins (chylomicrons, VLDL, LDL, lipoprotein(A)). Malabsorption of the antioxidant vitamin E occurs, leading to spinocerebellar and retinal degeneration. {ECO:0000269|PubMed:10679949, ECO:0000269|PubMed:10946006, ECO:0000269|PubMed:22236406, ECO:0000269|PubMed:23475612, ECO:0000269|PubMed:25108285, ECO:0000269|PubMed:26224785, ECO:0000269|PubMed:8939939}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Pathway
Fat digestion and absorption - Homo sapiens (human);Statin Pathway, Pharmacodynamics;Demo complete;Statin Pathway;Chylomicron assembly;VLDL assembly;Plasma lipoprotein assembly;Transport of small molecules;Glycerophospholipid metabolism;Plasma lipoprotein assembly, remodeling, and clearance (Consensus)

Recessive Scores

pRec
0.450

Intolerance Scores

loftool
0.582
rvis_EVS
1.43
rvis_percentile_EVS
94.99

Haploinsufficiency Scores

pHI
0.364
hipred
Y
hipred_score
0.589
ghis

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.691

Gene Damage Prediction

AllRecessiveDominant
MendelianHighMediumHigh
Primary ImmunodeficiencyHighHighHigh
CancerHighHighHigh

Mouse Genome Informatics

Gene name
Mttp
Phenotype
growth/size/body region phenotype; homeostasis/metabolism phenotype; embryo phenotype; liver/biliary system phenotype; hematopoietic system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan);

Zebrafish Information Network

Gene name
mttp
Affected structure
subintestinal vein
Phenotype tag
abnormal
Phenotype quality
morphology

Gene ontology

Biological process
lipid metabolic process;protein secretion;phospholipid transport;triglyceride transport;plasma lipoprotein particle assembly;chylomicron assembly;very-low-density lipoprotein particle assembly;lipoprotein metabolic process;cholesterol homeostasis
Cellular component
endoplasmic reticulum;endoplasmic reticulum lumen;Golgi apparatus;basolateral plasma membrane;receptor complex
Molecular function
lipid transporter activity;protein binding;phospholipid transporter activity;lipid binding;protein heterodimerization activity